Bed Bath & Beyond Inc. (NasdaqGS:BBBY) Quant Signal & Valuation Review

(NASDAQ:BBBY) by 1.7% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The number of shares now owned by investors are 109.21 mln. It turned negative, as 77 investors sold BBBY shares while 140 reduced holdings.

Bed Bath & Beyond Inc., launched on October 5, 1971, is a retailer, which operates under the names Bed Bath & Beyond (BBB), Christmas Tree Shops, Christmas Tree Shops andThat! or andThat! Next Financial Group, Inc bolstered its stake by buying 150 shares an increase of 83.3% in the quarter.

Now we will discuss the financial strength of Bed Bath & Beyond Inc. Quantbot Technologies LP acquired a new position in Bed Bath & Beyond during the first quarter valued at approximately $106,000. Cubic Asset Management Ltd Company owns 25,920 shares or 0.23% of their United States portfolio. Acrospire Investment Management LLC boosted its position in Bed Bath & Beyond by 7.1% in the third quarter. LSV Asset Management now owns 1,315,995 shares of the retailer’s stock valued at $40,006,000 after purchasing an additional 584,700 shares during the period. FMR LLC now owns 13,418,679 shares of the retailer’s stock valued at $529,501,000 after purchasing an additional 551,019 shares during the period. Quinn Opportunity Partners LLC boosted its stake in Bed Bath & Beyond by 15.3% during the second quarter. (NASDAQ:BBBY) has a 20-Day average volume of 5.16 Million. The share price has moved backward from its 20 days moving average, trading at a distance of -15.31% and stays -18.36% away from its 50 days moving average.

“CEO at Bed Bath & Beyond Inc., TEMARES STEVEN H on 2017-05-09 Sell 96109 shares of the company at a price of $37.37″. The stock has a market capitalization of $3.25 billion, a price-to-earnings ratio of 5.936 and a beta of 1.11. (NASDAQ:BBBY) were released by: and their article: “Bed Bath & Beyond Owed Refund Over Store Credits: NJ Court” published on September 25, 2017 as well as’s news article titled: “Bed Bath & Beyond earnings miss widely, stock plunges 18%” with publication date: September 19, 2017.

For the current quarter, 21 analysts are projecting a mean EPS of $0.39/share.

For the Current Quarter, the growth estimate for Bed Bath & Beyond -54.1%, while for the Next Quarter the stock growth estimate is -21.2%. The business had revenue of $2.94 billion for the quarter, compared to the consensus estimate of $3.01 billion. In addition, the company expects net earnings per diluted share for the full-year to be around $3 compared to a previous expectation of $4. Leuthold Gru Ltd Liability Company has invested 0.28% in Bed Bath & Beyond Inc. Analysts have placed a $25.11 price target on Bed Bath & Beyond Inc., suggesting a 8.89% gain from recent close.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, January 16th. (NASDAQ:BBBY). Rampart Invest Mngmt Ltd Com invested in 0.02% or 1,909 shares. The ex-dividend date of this dividend is Wednesday, June 14th.

In an overview of the current analyst recommendations, Buy count is 2 and Overweight is 0 while the number of analysts recommending Sell and Underweight are 5 and 1, respectively. Cibc World Mkts Corporation invested 0.01% in Bed Bath & Beyond Inc. The MF Rank of Bed Bath & Beyond Inc. “(BBBY)” was originally posted by StockNewsTimes and is the sole property of of StockNewsTimes. If you are accessing this piece of content on another website, it was illegally copied and reposted in violation of USA & global trademark and copyright legislation. The correct version of this report can be read at

A number of other equities research analysts have also weighed in on BBBY. As per Thursday, June 23, the company rating was maintained by Goldman Sachs. ValuEngine downgraded shares of Bed Bath & Beyond from a buy rating to a hold rating in a report on Friday, September 1st. Wedbush cut their price target on shares of Bed Bath & Beyond from $42.00 to $38.00 and set a neutral rating for the company in a report on Tuesday, July 4th. UBS AG reissued a “hold” rating and set a $24.00 price objective (down previously from $30.00) on shares of Bed Bath & Beyond in a research note on Wednesday, September 20th. Wolfe Research lowered Bed Bath & Beyond from a “peer perform” rating to an “underperform” rating and set a $31.00 price target on the a research note on Monday, June 19th.

Leave a Reply

Your email address will not be published. Required fields are marked *